{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:59Z","timestamp":1791328919242,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1124\/mol.107.036459","type":"journal-article","created":{"date-parts":[[2007,6,15]],"date-time":"2007-06-15T00:59:09Z","timestamp":1181869149000},"page":"563-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor"],"prefix":"10.1016","volume":"72","author":[{"given":"Jessica","family":"Huyet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory M.","family":"Pinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Fagart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Edith","family":"Rafestin-Oblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.036459_REF1","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.036459_REF2","first-page":"S49","article-title":"Regulation of sodium transport by steroid hormones","volume":"65","author":"Bonvalet","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/mol.107.036459_REF3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography and NMR system: A new software suite for macromolecular structure determination","volume":"54","author":"Br\u00fcnger","year":"1998","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.107.036459_REF4","first-page":"199","article-title":"Spirolactones: clinical and pharmacologic studies","volume":"7","author":"Corvol","year":"1977","journal-title":"Adv Nephrol Necker Hosp"},{"key":"10.1124\/mol.107.036459_REF5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj3150421","article-title":"Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure","volume":"315","author":"Couette","year":"1996","journal-title":"Biochem J"},{"key":"10.1124\/mol.107.036459_REF6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxyspirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.036459_REF7","first-page":"725","article-title":"Firefly luciferase gene: structure and expression in mammalian cells","volume":"7","author":"de","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.107.036459_REF8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"key":"10.1124\/mol.107.036459_REF9","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J"},{"key":"10.1124\/mol.107.036459_REF10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1124\/mol.104.010710","article-title":"The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor","volume":"67","author":"Fagart","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.036459_REF11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nsmb939","article-title":"Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension","volume":"12","author":"Fagart","year":"2005","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/mol.107.036459_REF12","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1073\/pnas.95.6.2973","article-title":"Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists","volume":"95","author":"Fejes-T\u00f3th","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.036459_REF13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","article-title":"The evolution of aldosterone antagonists","volume":"217","author":"Garthwaite","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.107.036459_REF14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1124\/mol.107.036459_REF15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/nar\/19.7.1563","article-title":"Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter","volume":"19","author":"Gouilleux","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.107.036459_REF16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.107.036459_REF17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int"},{"key":"10.1124\/mol.107.036459_REF18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0092-8674(84)90472-0","article-title":"Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma","volume":"39","author":"Herbomel","year":"1984","journal-title":"Cell"},{"key":"10.1124\/mol.107.036459_REF19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.19.3.221","article-title":"Aldosterone regulation of gene transcription leading to control of ion transport","volume":"19","author":"Horisberger","year":"1992","journal-title":"Hypertension"},{"key":"10.1124\/mol.107.036459_REF20","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.107.036459_REF21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallogr A"},{"key":"10.1124\/mol.107.036459_REF22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1107\/S0021889893005588","article-title":"Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants","volume":"26","author":"Kabsch","year":"1993","journal-title":"J Appl Crystallogr"},{"key":"10.1124\/mol.107.036459_REF23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1107\/S0907444993011333","article-title":"Detection, delineation, measurement and display of cavities in macromolecular structures","volume":"50","author":"Kleywegt","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.107.036459_REF24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallogr"},{"key":"10.1124\/mol.107.036459_REF25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol Cell"},{"key":"10.1124\/mol.107.036459_REF26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.107.036459_REF27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tibs.2004.04.006","article-title":"Mechanism of the nuclear receptor molecular switch","volume":"29","author":"Nagy","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/mol.107.036459_REF28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/jm50001a002","article-title":"Aldosterone antagonists. 1. Synthesis and activities of 6 beta,7 beta:15 beta,16 betadimethylene steroidal spirolactones","volume":"28","author":"Nickisch","year":"1985","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.036459_REF29","doi-asserted-by":"crossref","first-page":"E386","DOI":"10.1152\/ajpendo.2000.279.2.E386","article-title":"The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes","volume":"279","author":"Penfornis","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/mol.107.036459_REF30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mce.2003.10.053","article-title":"Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension","volume":"217","author":"Pinon","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.107.036459_REF31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.107.036459_REF32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.107.036459_REF33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1124\/mol.62.6.1306","article-title":"11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells","volume":"62","author":"Rafestin-Oblin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.036459_REF34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/mol.107.036459_REF35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","volume":"16","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/mol.107.036459_REF36","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/endo.136.12.7588320","article-title":"The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent","volume":"136","author":"Souque","year":"1995","journal-title":"Endocrinology"},{"key":"10.1124\/mol.107.036459_REF37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1107\/S0907444903028956","article-title":"Likelihood-enhanced fast rotation functions","volume":"60","author":"Storoni","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.107.036459_REF37a","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1995.2464","article-title":"Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping","volume":"215","author":"Trapp","year":"1995","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.036459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:54:29Z","timestamp":1739966069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24045528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0026895X24045528"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.036459","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.036459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}